{"id":10691,"date":"2025-03-12T13:34:15","date_gmt":"2025-03-12T18:34:15","guid":{"rendered":"https:\/\/ibio.org\/?p=10691"},"modified":"2025-03-12T13:34:15","modified_gmt":"2025-03-12T18:34:15","slug":"grant-report-critical-federal-funding-opportunities-amidst-changing-landscape","status":"publish","type":"post","link":"https:\/\/ibio.org\/grant-report-critical-federal-funding-opportunities-amidst-changing-landscape\/","title":{"rendered":"GRANT REPORT: Critical Federal Funding Opportunities Amidst Changing Landscape"},"content":{"rendered":"<p>In partnership with G2G Consulting, iBIO is pleased to provide members with the March 2025 Government Bioscience Grants (GBG) report. This month&#8217;s report identifies 105 non-dilutive funding opportunities despite the challenging federal funding environment. With recent executive orders significantly impacting federal research priorities and funding availability, this resource is more crucial than ever for organizations seeking government support for innovation.<\/p>\n<p>&nbsp;<\/p>\n<h3>FUNDING HIGHLIGHTS<\/h3>\n<p>\u2022 Biotechnology &amp; Biomanufacturing: BARDA is planning support for prizes to advance clinical testing of vaccines using new GMP approaches for single dose formulations and novel manufacturing platforms<\/p>\n<p>\u2022 Cognitive and Brain Health: NIH has released a Notice of Special Interest on digital technologies to identify early changes in individuals at risk for Alzheimer&#8217;s disease<\/p>\n<p>\u2022 Medical Countermeasures: DTRA&#8217;s CBD Program has announced a call for topics including tissue protective and regenerative medicine, and broad spectrum countermeasures against chemicals of concern<\/p>\n<p>\u2022 Rare Disease Research: PCORI is supporting comparative effectiveness research for rare disease symptom management, diagnosis, and care delivery<\/p>\n<p>\u2022 Small Business Opportunities: Multiple DoD SBIR programs from SOCOM and the Defense Health Agency, plus a new Small Business On-Ramp Vehicle to support DHA medical R&amp;D efforts<\/p>\n<p>&nbsp;<\/p>\n<h3>MARK YOUR CALENDAR<\/h3>\n<p><strong>Monthly Funding Webinar<\/strong><br \/>\nDate: Thursday, March 20, 2025<br \/>\nTimes:<br \/>\n&#8211; 11:00-11:30 AM CT: FREE session open to all<br \/>\n&#8211; 11:30 AM-12:00 PM CT: Premium consultation for iBIO members<\/p>\n<p>*NEW FOR MARCH 2025*: To access the premium consultation segment, please utilize the specialized links found on page 2 or page 20 of the GBG report.<\/p>\n<p>&nbsp;<\/p>\n<h3>FEDERAL FUNDING LANDSCAPE UPDATE<\/h3>\n<p>Due to changes in federal government priorities outlined in recent executive orders, we&#8217;re seeing a substantially lower than average number of opportunities published in recent weeks. Many programs at institutions like the NIH have been scaled back or suspended. G2G remains committed to identifying and informing the community of opportunities amidst this changing landscape.<\/p>\n<p>&nbsp;<\/p>\n<h3>ACCESSING THE FULL REPORT<\/h3>\n<p>The complete March GBG report, containing all 105 funding opportunities across 20 research categories, is available through your iBIO membership portal. This comprehensive resource represents a vital tool for navigating the increasingly complex federal funding environment.<\/p>\n<p style=\"text-align: center;\"><a href='https:\/\/ibio.org\/wp-content\/uploads\/G2Gs-GBG-Report-for-iBIO-03-12-25.pdf' class='big-button bigblack' target=\"_blank\">Read the full report<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>In partnership with G2G Consulting, iBIO is pleased to provide members with the March 2025 Government Bioscience Grants (GBG) report. This month&#8217;s report identifies 105 non-dilutive funding opportunities despite the challenging federal funding environment. With recent executive orders significantly impacting federal research priorities and funding availability, this resource is more crucial than ever for organizations [&hellip;]<\/p>\n","protected":false},"author":12,"featured_media":10618,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[188,143],"tags":[212,172],"class_list":["post-10691","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-grants","category-ibio-news","tag-grants","tag-sbir"],"_links":{"self":[{"href":"https:\/\/ibio.org\/wp-json\/wp\/v2\/posts\/10691","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ibio.org\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ibio.org\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ibio.org\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/ibio.org\/wp-json\/wp\/v2\/comments?post=10691"}],"version-history":[{"count":2,"href":"https:\/\/ibio.org\/wp-json\/wp\/v2\/posts\/10691\/revisions"}],"predecessor-version":[{"id":10694,"href":"https:\/\/ibio.org\/wp-json\/wp\/v2\/posts\/10691\/revisions\/10694"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ibio.org\/wp-json\/wp\/v2\/media\/10618"}],"wp:attachment":[{"href":"https:\/\/ibio.org\/wp-json\/wp\/v2\/media?parent=10691"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ibio.org\/wp-json\/wp\/v2\/categories?post=10691"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ibio.org\/wp-json\/wp\/v2\/tags?post=10691"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}